您要查找的是不是：
- plasma thromboplastin factor D 血浆促凝血酶原激酶因子D
- plasma thromboplastin factor(Factor X) 血浆促凝血酶原激酶因子(第十因子), 血浆凝血活酶因子
- plasma thromboplastin factor 血浆促凝血酶原因子
- plasma thromboplastin factor A 血浆促凝血酶原激酶因子A
- plasma thromboplastin factor B 血浆促凝血酶原激酶因子B
- plasma thromboplastin factor C 血浆促凝血酶原激酶因子C
- plasma thromboplastin antecedent(Factor XI) 血浆凝血致活酶前体(第十一因子)
- plasma thromboplastin(factor IXa) 血浆促凝血酶原激酶, 凝血因子IXa
- Moreover, a set of performance indices, including deformability factor D, strength factor S , deformation energy factor Y and overall performance factor F, are presented to d... 而目前普遍采用的极限状态设计方法,是基于对结构弹塑性受力性能研究的深入以及人们对结构使用要求的提高而提出的。
- plasma thromboplastin antecedent 凝血因子XI
- The results indicated that the major factor affecting the deproteinization rate (DPR) was B (2 butanol), the sub major factor D (ethanol); while C (methanol) and E (NaCl) had little influence. 5因素 3水平正交试验的结果表明 ,影响脱蛋白率 ( DPR)的主要因素是 B(正丁醇 )、次主要因素是 D(乙醇 ) ,而因素 C(甲醇 )和 E(氯化钠 )的影响则较小 ;
- Plasma thromboplastin antecedent assay 血浆凝血激酶前质测定
- To explore the regulatory effects of thymic factor D(TFD) on the interleukin 6(IL 6) and tumour necrosis factor (TNF). IL 6 and TNF level was determined in 42 patients with various type of acute leukemia. 探讨胸腺因子D（TFD）对白血病患者白介素6（IL－6）和肿瘤坏死因子（TNF）的调控作用，以便在白血病治疗中正确使用TFD。
- plasma thromboplastin antecedent deficiency 血浆促凝血酶原激酶前体缺失症
- The results indicated that the major factor affecting the deproteinization rate (DPR) was B (2 butanol), the sub major factor D (ethanol);while C (methanol) and E (NaCl) had little influence. 5因素3水平正交试验的结果表明,影响脱蛋白率(DPR)的主要因素是B(正丁醇)、次主要因素是D(乙醇),而因素C(甲醇)和E(氯化钠)的影响则较小;
- plasma thromboplastin antecedent(PFA) 血浆凝血激酶前质, 凝血因子Ⅺ
- plasma thromboplastin antecedent(PTA) [化] 血浆促凝血酶原激酶前体; 凝血因子XI
- plasma thromboplastin antecedent, PTA 血浆促凝血酶原激酶前体, 凝血因子XI
- Plasma thromboplastin component assay 血浆凝血激酶片段测定
- plasma thromboplastin component deficiency 血浆促凝血酶原激酶成分缺乏
